GI Pop Quiz! is a flipped education approach that challenges learners to critically think through an individual patient case and see how their decisions compare with those of subject matter experts. The cases in this educational program cover:
- Changes with biosimilar adoption, including making the switch and new starts
- Interchangeable biosimilars
- Newly approved and emerging biosimilars
- Patient-provider communication
Learners will also be able to see how their responses compare with other participants to provide quick feedback and help learners understand their own knowledge gaps. Learners will also be able to participate in an in-activity discussion board to post their questions and have them answered by both peers and subject matter experts.
Learning objectives
- Evaluate safety, efficacy, and best practices for switching to a biosimilar
- Discuss impact of interchangeable designation on the use of biosimilars in clinician practice
- Consider updated data on newly approved and emerging biosimilar products
- Implement strategies for optimal patient-provider communication regarding switching to biosimilars.
Course director
Sara N. Horst, MD, MPH
Professor of Medicine
Division of Gastroenterology, Hepatology and Nutrition
Associate Vice Chair for Digital Health Operations, Department of Medicine
Assistant Chief for Clinical Informatics, Division of Gastroenterology, Hepatology and Nutrition
Vanderbilt University Medical Center
Supporter Acknowledgement
This educational program is supported by an independent educational grant from Mylan Inc., a Viatris Company, and Sandoz Inc.
CME Available
.25
This year’s postgraduate course has an innovative and engaging format designed to provide attendees with the latest updates in gastroenterology. Discussion will center on significant advances, high impact papers and guidelines with key points to enhance patient care and understanding of best practices. Talks will be organized into categories as follows:
- Diseases of the Esophagus
- Rena Yadlapati
- Joan Chen
- Sachin Wani
- Karthik Ravi
- Diseases of the Stomach and small bowel
- Carol Semrad
- Paul Moayyedi
- Linda Nguyen
- Satish Rao
- Diseases of the Pancreaticobiliary disease and Obesity
- Greg Cote
- Raman Muthusamy
- Allison Schuman
- Diseases of the Liver
- Lisa VanWagner
- David Goldberg
- Marina Serper
- Betsy Verna
- Diseases of the Colon
- Jordan Shapiro
- Michael Wallace
- Doug Corley
- Rachel Issaka
- Inflammatory Bowel Disease
- Maria Abreu
- Ryan Ungaro
- Edward Loftus
- Jessica Allegretti
Disclosures
Sara N. Horst discloses the following financial relationships:
- AbbVie, Consulting
- Takeda, Consulting
- Bristol Myers Squibb (BMS), Consulting
- Janssen, Consulting
ALL relevant financial relationships for this activity have been mitigated.
Accreditation Statement
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AGA Institute designates this this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, all faculty and planning partners must disclose all their financial relationships with ineligible companies held within the past 24 months. The AGA Institute implements a mechanism to identify and mitigate all conflicts of interest prior to delivering the educational activity to learners.
CME expiration date: June 30, 2025